Ticker: BCAB

BioAtla, Inc. (NASDAQ: BCAB) - Company Overview BioAtla, Inc. is a clinical-stage biopharmaceutical company focusing on developing conditionally active biologics (CABs) for cancer treatment. The company's innovative platform aims to create highly selective therapies that target tumor-specific ant...